Reading: The Impact of Lagged R&D Expenses on Firm Performance: Empirical Evidence from the BSE Healt...

Download

A- A+
Alt. Display

Research

The Impact of Lagged R&D Expenses on Firm Performance: Empirical Evidence from the BSE Healthcare Index

Authors:

Abhijit Sinha ,

Vidyasagar University, IN
About Abhijit
Department of Commerce
X close

Keyarani Mondal

Vidyasagar University, IN
About Keyarani
Department of Commerce
X close

Abstract

The study finds the impact of lagged Research and Development expenditure on financial performance. The investigation analyses 69 pharmaceutical companies included in the BSE healthcare index (India) using secondary data for the period of 2008 to 2017. The two dependent variables which are considered separately are Return on Asset (ROA) and Return on Equity (ROE). The two estimated regression models show that both the lagged value and its quadratic term have a significant influence on the accounting-based measures. With regard to the control variables, size and leverage are found to influence negatively whereas liquidity poses a positive effect on these two accounting-based performance measures. The article contributes by highlighting that the true relationship between R&D and financial performance is represented by a U-shaped curve as evident in few other studies.
How to Cite: Sinha, A. and Mondal, K., 2020. The Impact of Lagged R&D Expenses on Firm Performance: Empirical Evidence from the BSE Healthcare Index. Colombo Business Journal, 11(2), pp.114–141. DOI: http://doi.org/10.4038/cbj.v11i2.66
Published on 31 Dec 2020.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus